From: The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines
Cell line
Normoxia
24Â h hypoxia
72Â h hypoxia
LICR-HN2
2.26 ± 0.83
1.06 ± 1.42
3.34 ± 1.25
LICR-HN5
1.16 ± 0.35
0.60 ± 0.23
1.49 ± 0.60
SC263
1.05 ± 0.12
0.95 ± 0.16
0.81 ± 0.12